MedPath

Evaluation of the clinical- & cost-effectiveness of UltraSOund-guided RadioFrequency Ablation of Leiomyomas via the Transvaginal route (ESONATA)

Recruiting
Conditions
intrauterine leiomyomas, intrauterine fibroids, heavy menstrual bleeding
Registration Number
NL-OMON24224
Lead Sponsor
Máxima Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
99
Inclusion Criteria

1.Have selected Sonata, tomic myomectomy, laparoscopic hysterectomy for the treatment of leiomyomas
2.Presence of at least one submucous myoma (type 2) or transmural fibroid (type 2-5)
3.= 25 years of age at the time of enrollment
4.American Society of Anesthesiologist class 1 or 2

Exclusion Criteria

1.Clotting disorders
2.Inability to understand Dutch or English

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to return to work in days
Secondary Outcome Measures
NameTimeMethod
terine fibroid symptom and health-related quality of life, Reintervention rate, Complications,Costs, Satisfaction and recommendation to friend
© Copyright 2025. All Rights Reserved by MedPath